#Deloitte

Freeform Injection Molding cuts GHGs by 75%

” Without Freeform Injection Molding, we would never have completed the project,” says Anders Ohlhues Baandrup.

‍

As a research engineer at the Zealand University Hospital, he is committed to discovering innovative solutions to everyday challenges. Together with Danish injection molder Krebs& Co., and with funding from the Danish AM Hub, he has developed an intelligent device that solves the challenge of getting stool samples from weakened cancer patients.

‍

‍“Freeform Injection Molding has enabled us to get very far on a limited budget and with improved sustainability. Previously, we would have spent 50.000 EUR or more on development and prototyping, but with Freeform Injection Molding, we are at 2.000 €.” -Anders Ohlhues Baandrup, Research engineer, Zealand University Hospital

 

Improved sustainability has been an unexpected benefit of using Freeform Injection Molding for device development. Deloitte performed a lifecycle assessment of the prototyping process and found a 75 % reduction in greenhouse gas emissions.

‍

“Freeform Injection Molding is a boon for carbon footprints. Conventional injection mold tool manufacturing consumes enormous amounts of energy. Freeform Injection Molding substantially reduces this consumption,” -concludes Anders Ohlhues Baandrup.

 

Get in touch if you want to know more about how Freeform Injection Molding may contribute to more sustainable product development.

‍

Dan Deckelbaum
Trauma Surgeon and Critical Care Physician at the Montreal General Hospital